Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/AVE stock hub

ASX/AVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/AVEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
47.8M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/AVE
In the news

Latest news · ASX/AVE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-182.9
P25 -118.7P50 -49.4P75 -1.2
ROIC-83.5
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/AVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
178
Groups with data
11
Currency
AUD
Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Australia
Country code
AU
Employees
15
Employees Change
-3%
Employees Change Percent
-16.67
Enterprise value
AUD 43.1M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU0000047441
Last refreshed
2026-05-10
Market cap
AUD 47.8M
Price
AUD 0.01
Price currency
AUD
Rev Per Employee
82,517.47x
Sector
Healthcare
Sic
2834
Symbol
asx/AVE
Website
https://avecho.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-9.25%
EV Earnings
-9.76x
EV/Sales
34.83x
P/B ratio
30.62x
P/S ratio
38.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
Gross margin
71.77%
Gross Profit
AUD 888,376
Gross Profit Growth
3.34%
Gross Profit Growth Q
6.19%
Gross Profit Growth5 Y
9.9%
Net Income
AUD -4.4M
Net Income Growth Years
0%
Pretax Margin
-356.82%
Profit Per Employee
AUD -294,442
ROA
-40.85
Roa5y
-39.11
ROCE
-61.83
ROE
-182.9
Roe5y
-97.6
ROIC
-83.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-2.97%
Cagr15y
-15.27%
Cagr1y
225.26%
Cagr20y
-13.37%
Cagr3y
37.5%
Cagr5y
-7.31%
EPS Growth Years
0
Revenue Growth
9.28x
Revenue Growth Q
-17.4x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
53.94x
Revenue Growth5 Y
8.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
AUD 0.2
Assets
AUD 7.1M
Cash
AUD 4.7M
Current Assets
AUD 7.1M
Current Liabilities
AUD 709,203
Debt
AUD 14,473
Debt Equity
AUD 0.01
Equity
AUD 1.6M
Interest Coverage
-8.57
Liabilities
AUD 5.5M
Long Term Assets
AUD 49,425
Long Term Liabilities
AUD 4.8M
Net Cash
AUD 4.6M
Net Cash By Market Cap
AUD 9.74
Net Cash Growth
258.2%
Net Debt Equity
AUD -2.98
Tangible Book Value
AUD 1.6M
Tangible Book Value Per Share
AUD 0
WACC
11.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
9.95
Inventory Turnover
4.8
Net Working Capital
AUD 1.7M
Quick ratio
9.68
Working Capital
AUD 6.3M
Working Capital Turnover
AUD 0.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-3.08%
Dividend per share
AUD 0
Last Dividend
AUD 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-26.04%
1Y total return
225%
200-day SMA
0.01
3Y total return
160%
50-day SMA
0.01
50-day SMA vs 200-day SMA
50over200
5Y total return
-31.58%
All Time High
1.22
All Time High Change
-98.93%
All Time High Date
1996-02-22
All Time Low
0
All Time Low Change
1,200%
All Time Low Date
2024-10-23
ATR
0
Beta
1.18
Beta1y
-0.59
Beta2y
0.53
Ch YTD
44.44
High
0.01
High52
0.01
High52 Date
2026-05-08
High52ch
0%
Low
0.01
Low52
0
Low52 Date
2025-07-08
Low52ch
333.33%
Ma50ch
30%
Price vs 200-day SMA
60.49%
RSI
68.94
RSI Monthly
66.09
RSI Weekly
67.12
Sharpe ratio
1.35x
Sortino ratio
2.18
Total Return
-3.08%
Tr YTD
44.44
Tr15y
-91.68%
Tr1m
52.94%
Tr1w
8.33%
Tr3m
30%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -4M
Operating margin
-319.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
2,257,042,819%
Net Borrowing
-1,126,970
Shares Insiders
23.24%
Shares Institutions
0.01%
Shares Out
3,673,463,679
Shares Qo Q
6.04%
Shares Yo Y
3.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Average Volume
7,589,765.3x
Bv Per Share
0
Ch10y
-27.78
Ch15y
-91.88
Ch1m
52.94
Ch1w
8.33
Ch1y
225
Ch20y
-94.47
Ch3m
30
Ch3y
160
Ch5y
-31.58
Ch6m
136.4
Change
8.33%
Change From Open
8.33
Close
0.01
Days Gap
0
Depreciation Amortization
137,089
Dollar Volume
207,792.9
Earnings Date
2026-05-28
EBIT
AUD -4M
EBITDA
AUD -3.8M
EPS
AUD -0
F Score
4
Financing CF
1,185,859
Fiscal Year End
December
Founded
1,992
Is Primary Listing
1
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Ma150
0.01
Ma150ch
47.73%
Ma20
0.01
Ma20ch
21.5%
Net CF
2,288,957
Next Earnings Date
2026-05-28
Open
0.01
P OCF Ratio
43.29
Position In Range
100
Ppne
33,695
Price Date
2026-05-08
Ptbv Ratio
30.62
Relative Volume
2.32x
Revenue
1,237,762x
SBC By Revenue
31.81x
Share Based Comp
393,706
Tr20y
-94.33%
Tr6m
136.36%
Volume
15,984,069
Z Score
-52.54
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/AVE pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/AVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+225.0%
S&P 500 1Y: n/a
3Y total return
+160.0%
S&P 500 3Y: n/a
5Y total return
-31.6%
S&P 500 5Y: n/a
10Y total return
-26.0%
S&P 500 10Y: n/a
Ownership

Who owns ASX/AVE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+23.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+3.1%
Negative means the company is buying back shares.
Technical

ASX/AVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
68.9
Neutral momentum band
Price vs 200-day MA
+60.5%
50/200-day relationship not available
Beta (5Y)
1.18
Moves roughly with the market
Sharpe ratio
1.35
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/AVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/AVE stock rating?

asx/AVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/AVE analysis?

The full report lives at /stocks/asx/AVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/AVE?

The latest report frames asx/AVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/AVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

asx/AVE stock profile: metrics, valuation and analysis | وكيل سوق الأسهم بالذكاء الاصطناعي